Measuring What Matters in Markedly Treatment-Resistant Depression: Insights from the RECOVER Trial
Shyam Tailor
How we measure depression matters—especially in the most severely ill patients.
In a recently accepted manuscript in the Journal of Affective Disorders, our team analyzed how three widely used depression rating scales perform in patients with markedly treatment-resistant depression (TRD) enrolled in the RECOVER trial. As a co-author and investigator at UTHealth Houston, I am proud to contribute to this important work, which helps clarify how we should assess outcomes in some of the most...